Company Filing History:
Years Active: 1999-2008
Title: The Innovative Contributions of Mark R. Schmitt
Introduction
Mark R. Schmitt, based in Trenton, NJ, has made significant strides in the field of biochemistry and pharmacology through his inventions. With a total of two patents to his name, his work primarily focuses on applications that target cancer treatment and plant protection.
Latest Patents
One of Schmitt's latest patents is titled "Substituted-triazolopyrimidines as anticancer agents." This invention presents a method for treating or inhibiting the growth of cancerous tumor cells in mammals. By administering an effective amount of a substituted triazolopyrimidine derivative or its pharmaceutically acceptable salt, this invention aims to promote microtubule polymerization and potentially stop cancerous growth in its tracks.
Another notable patent from Schmitt is "Newly characterized oxalate and uses therefor." This innovation revolves around methods for using oxalate oxidase in plant pathology. The invention describes a substantially pure gene encoding the oxalate oxidase enzyme, which can be stably incorporated into foreign plant hosts, providing them protection against oxalic acid through a specific enzyme treatment.
Career Highlights
Throughout his career, Mark R. Schmitt has collaborated with renowned companies such as Zeneca Limited and Wyeth. His work at these organizations has not only advanced his professional development but has also contributed to significant innovations in pharmaceutical and agricultural sectors.
Collaborations
In his journey as an inventor, Schmitt has worked alongside talented individuals, including Christina L Hartman and Sarjit S Johal. These collaborations have played a pivotal role in the development and realization of his inventions.
Conclusion
Mark R. Schmitt's innovative thoughts and groundbreaking patents in cancer treatment and agricultural protection emphasize the impact of dedicated inventors in improving health and agriculture. With his ongoing contributions, Schmitt continues to demonstrate the importance of innovation in addressing some of the world's critical challenges.